GILD
Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh · BCBA:GILD
70,300.00 ARS−275.00 −0.39%
Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh (BCBA:GILD) last traded at 70,300.00 ARS, down 0.39% on the day. Over the past year the stock is up 56.29%. Its 52-week range is 43,220.00 to 72,400.00. It is in the Health Technology sector (Biotechnology).
Key statistics
Open70,650.00
Day range68,900.00 – 70,950.00
52-week range43,220.00 – 72,400.00
Volume572
Average volume (10 days)1.21 K
Market cap (USD)211.64 B
EPS (TTM) (USD)−0.6871
Dividend yield1.04%
Beta (1 year)−0.0737
Revenue (TTM) (USD)29.35 B
Employees17.00 K
Performance
+5.83%1 week
+17.80%1 month
+35.98%3 months
+42.19%6 months
+50.02%Year to date
+56.29%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
- Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Is Maintained at Sector Outperform by ScotiabankDow Jones Newswires · 30 Oct 2026
- Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor ConferencesBusinessWire · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.